A study on community-acquired pneumonia revealed that ANGPTL4 levels were about 3.2 times higher in patients with severe pneumonia than those with non-severe disease (median of 1441.70 pg/mL versus 453.53 pg/mL, p < 0.001) [42]. This evidence concerns the gene ANGPTL4 and susceptibility to pneumonia measurement.